Viewing nowCombinationDouble Poseidon 5/160mg
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Joah Pharmaceutical Co., Ltd.

MFDS item code 201701499 · Approved 2017.03.29 · Insurance code 644603640
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients: Administration of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients under 18 years of age.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, the medication should be discontinued immediately. Patients allergic to this medication's active ingredients or similar compounds, pregnant or nursing women, and those with severe renal or liver disease should avoid taking this medication. Patients with insufficient sodium or fluid within the body should correct their condition before taking this medication, and they should be closely monitored as low blood pressure may occur during treatment. Patients with high potassium levels or those using medications that can increase potassium levels should frequently check their potassium levels. Patients with renal vascular abnormalities or those who have undergone kidney transplants should closely monitor renal function while taking this medication. This medication should be used cautiously in patients with heart failure or myocardial infarction, and frequent checks of heart function and blood pressure are necessary. Dizziness or fatigue may occur while driving or operating machinery; caution is advised. In the case of overdose, severe hypotension or arrhythmias may occur, and appropriate medical treatment should be sought immediately if symptoms arise. This medication can interact with other antihypertensives, potassium-sparing diuretics, and some anti-inflammatory drugs; thus, patients should consult their doctor or pharmacist if they are taking any other medications. Women planning to become pregnant or currently pregnant should not use this medication, and nursing mothers should also refrain from taking it. Safety and efficacy have not been established for children under 18 years of age, and it is not recommended for them. Elderly patients may be given doses similar to those for the general adult population, but caution may be necessary depending on their condition. If any unusual symptoms or discomfort occur while taking this medication, patients should consult their healthcare provider immediately.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, lower back pain, arthritis, muscle spasm, fatigue, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, tiredness, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vessel edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, excessive muscle tone, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturia, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervousness, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, nervousness, sensory impairment, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container, protected from air and moisture, and kept at room temperature between 1 and 30 degrees Celsius. Doing so will help maintain the medication's effectiveness for a long time.
Dark yellow, oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Joah Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.